HealthEquity, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: +7.6%
EBITDA: +20.8%
EBIT: +26.0%
EPS: +93.5%
Free cash flow: +457.2%
Operating cash flow: +44.4%

Forward estimates

Revenue: +7.7%
EBITDA: -30.2%
EPS: +73.6%

Three-year CAGR

Revenue: +15.1%
EBITDA: +41.8%
EBIT: +104.6%
Net income: +96.5%
EPS: +96.1%
Free cash flow: +143.5%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.